OSTEOPOROSIS, POSTMENOPAUSAL
Clinical trials for OSTEOPOROSIS, POSTMENOPAUSAL explained in plain language.
Never miss a new study
Get alerted when new OSTEOPOROSIS, POSTMENOPAUSAL trials appear
Sign up with your email to follow new studies for OSTEOPOROSIS, POSTMENOPAUSAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to stop bone loss when switching osteoporosis treatments
Disease control OngoingThis study is testing whether a different medication, zoledronate, given as an infusion, can help maintain bone density in women who are stopping their current osteoporosis treatment, denosumab. It involves 200 postmenopausal women who have been on denosumab for at least two year…
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope to stop fractures in frail elderly women
Disease control OngoingThis study is testing whether a specific sequence of two bone-strengthening medications works better than standard care for older women with osteoporosis who live in nursing homes or assisted living. About 184 women aged 65 and older will receive either the new two-step treatment…
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Susan L. Greenspan • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Could arm workouts plus a drug build stronger bones?
Disease control TerminatedThis study aimed to see if doing arm exercises while taking a bone-building medication (PTH) could improve bone density in the forearm. It was designed for postmenopausal women over 45 with osteoporosis and a high risk of fractures. The trial was withdrawn before any participants…
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC